Elevated serum calprotectin as an inflammatory marker in obstructive sleep apnea

References

• Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897–1904. DOI:10.1172/JCI118235
   PubMed Web of Science ®Google Scholar
• Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000;102(21):2607–2610. DOI:10.1161/01.CIR.102.21.2607
   PubMed Web of Science ®Google Scholar
• Colla-Machado PE, Luzzi AA, Balian NR, et al. Prevalence of silent cerebrovascular lesions in patients with obstructive sleep apnea syndrome. Rev Neurol. 2016;62(3):113–117.
   PubMed Web of Science ®Google Scholar
• Savaş Ö, Süslü AE, Lay I, et al. Assessment of the relationship between polysomnography parameters and plasma malondialdehyde levels in patients with obstructive sleep apnea. Eur Arch Oto-Rhino-L. 2019;276(12):3533–3538. DOI:10.1007/s00405-019-05536-z
   PubMed Web of Science ®Google Scholar
• Fleming WE, Ferouz-Colborn A, Samoszuk MK, et al. Blood biomarkers of endocrine, immune, inflammatory, and metabolic systems in obstructive sleep apnea. Clin Biochem. 2016;49(12):854–861. DOI:10.1016/j.clinbiochem.2016.05.005
   PubMed Web of Science ®Google Scholar
• Altintas N, Cetinoglu E, Yuceege M, et al. Neutrophil-to-lymphocyte ratio in obstructive sleep apnea; a multi center, retrospective study. Eur Rev Med Pharmacol Sci. 2015;19(17):3234–3240.
   PubMed Web of Science ®Google Scholar
• De Santis S, Cambi J, Tatti P, et al. Changes in ghrelin, leptin and pro-inflammatory cytokines after therapy in obstructive sleep apnea syndrome (OSAS) patients. Otolaryngol Pol. 2015;69(2):1–8. DOI:10.5604/00306657.1147029
   PubMedGoogle Scholar
• Stříž I, Trebichavský I. Calprotectin—a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004;53:245–253.
   PubMed Web of Science ®Google Scholar
• Torun MT, Unver E, Yalcin Y, et al. The importance of calprotectin levels in obstructive sleep apnea syndrome severity. Curr Med Res Opin. 2018;34(3):401–405. DOI:10.1080/03007995.2017.1383890
   PubMed Web of Science ®Google Scholar
• Cholidou KG, Kostakis ID, Manali ED, et al. Calprotectin: a protein related to cardiovascular risk in adult patients with obstructive sleep apnea. Cytokine. 2013;61(3):917–923. DOI:10.1016/j.cyto.2012.12.014
   PubMed Web of Science ®Google Scholar
• Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. J Clin Sleep Med. 2012;8(5):597–619. DOI:10.5664/jcsm.2172
   PubMed Web of Science ®Google Scholar
• Kent BD, Ryan S, McNicholas WT. Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol. 2011;178(3):475–481.
   PubMed Web of Science ®Google Scholar
• Hatipoglu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration. 2003;70(6):665–671.
   PubMed Web of Science ®Google Scholar
• Gozal D, Jortani S, Snow AB, et al. Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med. 2009;180(12):1253–1261. DOI:10.1164/rccm.200905-0765OC
   PubMed Web of Science ®Google Scholar
• Kheirandish-Gozal L, McManus CJT, Kellermann GH, et al. Urinary neurotransmitters are selectively altered in children with obstructive sleep apnea and predict cognitive morbidity. Chest. 2013;143(6):1576–1583. DOI:10.1378/chest.12-2606
   PubMed Web of Science ®Google Scholar
• Li Y, Chongsuvivatwong V, Geater A, et al. Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. Sleep Med. 2009;10(1):95–103. DOI:10.1016/j.sleep.2007.11.013
   PubMed Web of Science ®Google Scholar
• Minoguchi K, Tazaki T, Yokoe T, et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest. 2004;126(5):1473–1479. DOI:10.1378/chest.126.5.1473
   PubMed Web of Science ®Google Scholar
• Shi YK, Chen JX, Huang Y, et al. Serum S100A12 levels are associated with the presence and severity of obstructive sleep apnea syndrome in male patients. Sleep Breath. 2014;18(2):269–274. DOI:10.1007/s11325-013-0876-6
   PubMed Web of Science ®Google Scholar
• De Luca Canto G, Pacheco-Pereira C, Aydinoz S, et al. Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med. 2015;11(1):27–36. DOI:10.5664/jcsm.4358
   PubMed Web of Science ®Google Scholar
• Diken ÖE, Arslan M, Deniz H. Neutrophil to Lymphocyte Ratio in obstructive sleep apnea syndrome. Bozok Med J. 2018;8(4):1–6. DOI:10.16919/bozoktip.373792
   Google Scholar
• Koseoglu S, Ozcan KM, Ikinciogullari A, et al. Relationship between neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and obstructive sleep apnea syndrome. Adv Clin Exp Med. 2015;24(4):623–627. DOI:10.17219/acem/58969
   PubMed Web of Science ®Google Scholar
• Azramezani Kopi T, Shahrokh S, Mirzaei S, et al. The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study. Gastroenterol Hepatol Bed Bench. 2019;12(3):183–189.
   PubMedGoogle Scholar
• Wang Y, Liang Y. Clinical significance of serum calprotectin level for the disease activity in active rheumatoid arthritis with normal C-reactive protein. Int J Clin Exp Pathol. 2019;12(3):1009–1014.
   PubMed Web of Science ®Google Scholar
• Croce K, Gao H, Wang Y, et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation. 2009;120(5):427–436. DOI:10.1161/CIRCULATIONAHA.108.814582
   PubMed Web of Science ®Google Scholar
• Baumann M, Schmaderer C, Burkhardt K, et al. MRP8/14 is associated with systemic inflammation in stable coronary atherosclerosis in men. Eur J Clin Invest. 2011;41(12):1261–1267. DOI:10.1111/j.1365-2362.2011.02530.x
   PubMed Web of Science ®Google Scholar
• Kim J, Bhattacharjee R, Snow AB, et al. Myeloid-related protein 8/14 levels in children with obstructive sleep apnoea. Eur Respir J. 2010;35(4):843–850. DOI:10.1183/09031936.00075409
   PubMed Web of Science ®Google Scholar
• Kim J, Lee S, Bhattacharjee R, et al. Leukocyte telomere length and plasma catestatin and myeloid-related protein 8/14 concentrations in children with obstructive sleep apnea. Chest. 2010;138(1):91–99. DOI:10.1378/chest.09-2832
   PubMed Web of Science ®Google Scholar
• Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–1235. DOI:10.1056/NEJM199304293281704
   PubMed Web of Science ®Google Scholar
• Mortensen OH, Nielsen AR, Erikstrup C, et al. Calprotectin–a novel marker of obesity. PLoS One. 2009;4(10):e7419.
   PubMed Web of Science ®Google Scholar
• Kum RO, Baklaci D, Ozcan M, et al. Increased risk of cerebral white matter lesions in obstructive sleep apnea syndrome. Sleep Biol Rhythms. 2017;15(1):49–55. DOI:10.1007/s41105-016-0079-1
   Web of Science ®Google Scholar